Registered entities
Prellis Biologics, Inc
Reg. No. 81-5455517United States
Innovation
14 patent families (5 granted) — focus: Chemistry & metallurgy, Operations & transport, Human necessities; filing pace slowing. Cited 1,228 times.
| Year | Filings |
|---|---|
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Social engagement
Social engagement: 15.5K social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Celesta Capital, Avidity Partners, Khosla Ventures, True Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 79% |
| Accelerator & incubator | 2 | 14% |
| Bank & private debt | 1 | 7% |
Hiring activity
Hires occasionally
2 roles tracked across 1 of the last 12 months
19 Nov 2025 · Business Development Director/Senior Director · Berkeley
14 Nov 2025 · Director/Sr. Director, Inflammation · Berkeley
Based on job postings tracked across public sources.
Recent activity
23 Sep 2025
Partnership
Eli Lilly and Company